Related references
Note: Only part of the references are listed.Dual-target kinase drug design: Current strategies and future directions in cancer therapy
Dejuan Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
A Review on Recent Synthetic Strategies and Pharmacological Importance of 1,3-Thiazole Derivatives
Swarnagowri Nayak et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2019)
Water-Mediated Ceric Ammonium Nitrate Catalyzed C-C/C-N Bond Formation: Convenient Access to Polyfunctionalized Pyrazoles via Multicomponent Reaction
Vikas D. Kadu et al.
ASIAN JOURNAL OF CHEMISTRY (2019)
Using Physicochemical Measurements to Influence Better Compound Design
Shenaz B. Bunally et al.
SLAS DISCOVERY (2019)
One-pot PEG-mediated syntheses of 2-(2-hydrazinyl) thiazole derivatives: novel route
Dattatraya G. Raut et al.
JOURNAL OF SULFUR CHEMISTRY (2018)
Recent Developments and Biological Activities of 2-Aminothiazole Derivatives
Mohamed Ezzat Khalifa
ACTA CHIMICA SLOVENICA (2018)
Hydrazide-hydrazones as potential antimicrobial agents: overview of the literature since 2010
Lukasz Popiolek
MEDICINAL CHEMISTRY RESEARCH (2017)
Peptides with Dual Antimicrobial and Anticancer Activities
Mario R. Felicio et al.
FRONTIERS IN CHEMISTRY (2017)
Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent
Mubarak H. Shaikh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Recent developments of 2-aminothiazoles in medicinal chemistry
Debasis Das et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Novel Dual Small-Molecule HIV inhibitors: Scaffolds and Discovery Strategies
Anran Song et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
2-Aminothiazole derivatives as antimycobacterial agents: Synthesis, characterization, in vitro and in silico studies
Parameshwar Makam et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among US FDA Approved Pharmaceuticals
Edon Vitaku et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
2-(2-Hydrazinyl)thiazole derivatives: Design, synthesis and in vitro antimycobacterial studies
Parameshwar Makam et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Thiolactomycin-based β-Ketoacyl-AcpM Synthase A (KasA) Inhibitors FRAGMENT-BASED INHIBITOR DISCOVERY USING TRANSIENT ONE-DIMENSIONAL NUCLEAR OVERHAUSER EFFECT NMR SPECTROSCOPY
Kanishk Kapilashrami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Structural Basis for the Recognition of Mycolic Acid Precursors by KasA, a Condensing Enzyme and Drug Target from Mycobacterium Tuberculosis
Johannes Schiebel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Hydrazides/Hydrazones as Antimicrobial and Anticancer Agents in the New Millennium
Pradeep Kumar et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
The influence of lipophilicity in drug discovery and design
John A. Arnott et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Genetic variants in antioxidant pathway: Risk factors for hepatotoxicity in tuberculosis patients
Kazutaka Nanashima et al.
TUBERCULOSIS (2012)
Genitourinary tuberculosis: historical and basic science review: past and present
Thaddaeus Zajaczkowski
CENTRAL EUROPEAN JOURNAL OF UROLOGY (2012)
The β-Ketoacyl-ACP Synthase from Mycobacterium tuberculosis as Potential Drug Targets
V. Singh et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives
Afsheen Arshad et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Probing the links between in vitro potency, ADMET and physicochemical parameters
M. Paul Gleeson et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Evidence for Oxidative Stress and Defective Antioxidant Response in Guinea Pigs with Tuberculosis
Gopinath S. Palanisamy et al.
PLOS ONE (2011)
Impact of ion class and time on oral drug molecular properties
Paul D. Leeson et al.
MEDCHEMCOMM (2011)
Antioxidant activity in vitro of the selenium-contained protein from the Se-enriched Bifidobacterium animalis 01
Qian Shen et al.
ANAEROBE (2010)
Synthesis and antituberculosis activity of some N-pyridyl-N′-thiazolylhydrazine derivatives
Guelhan Turan-Zitouni et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety
Nuray Ulusoy Guzeldemirci et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Lipophilicity in drug discovery
Michael J. Waring
EXPERT OPINION ON DRUG DISCOVERY (2010)
Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability
Michael J. Waring
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Synthesis of 4-benzyl-1,3-thiazole derivatives as potential anti-inflammatory agents: An analogue-based drug design approach
Ritesh N. Sharma et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2009)
Identification of 2-Aminothiazole-4-Carboxylate Derivatives Active against Mycobacterium tuberculosis H37Rv and the β-Ketoacyl-ACP Synthase mtFabH
Qosay Al-Balas et al.
PLOS ONE (2009)
Crystal Structures of Mycobacterium tuberculosis KasA Show Mode of Action within Cell Wall Biosynthesis and its Inhibition by Thiolactomycin
Sylvia R. Luckner et al.
STRUCTURE (2009)
Hybrid molecules with a dual mode of action: Dream or reality?
Bernard Meunier
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Structure-assisted discovery of an aminothiazole derivative as a lead molecule for inhibition of bacterial fatty-acid synthesis
Guenter Pappenberger et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2007)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Biological activities of hydrazone derivatives
Sevim Rollas et al.
MOLECULES (2007)
Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives
Elif Gursoy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2007)
Global incidence of multidrug-resistant tuberculosis
Matteo Zignol et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Risk factors for multidrug resistant tuberculosis in Europe: a systematic review
A Faustini et al.
THORAX (2006)
Total antioxidant levels are low during active TB and rise with anti-tuberculosis therapy
I Wiid et al.
IUBMB LIFE (2004)
Time-related differences in the physical property profiles of oral drugs
PD Leeson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Share Paper
